Biohaven Ltd. (BHVN) Insider Trading Disclosures
Biohaven Ltd. (BHVN) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BHVN
CIK: 1935979
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: D8
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerDevon Brady
Audit LocationStamford, Connecticut, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-08 | 8-K | 0001935979-26-000080 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | FORM 4 | 0001704186-26-000006 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-04 | 8-K | 0001935979-26-000077 | View SEC Doc Filr Page |
| 8-K | 2026-08-26 | 2026-08-26 | 8-K | 0001935979-26-000072 | View SEC Doc Filr Page |
| 3 | 2026-08-14 | 2026-08-06 | FORM 3 | 0002150506-26-000002 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000919574-26-005259 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001935979-26-000067 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001935979-26-000066 | View SEC Doc Filr Page |
| 8-K | 2026-08-07 | 2026-08-03 | 8-K | 0001935979-26-000060 | View SEC Doc Filr Page |
| 3 | 2026-07-17 | 2026-07-09 | FORM 3 | 0002146037-26-000003 | View SEC Doc Filr Page |
| 8-K | 2026-07-09 | 2026-07-09 | 8-K | 0001935979-26-000053 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-08 | — | SCHEDULE 13G/A Filing | 0001274173-26-000170 | View SEC Doc Filr Page |
| 8-K | 2026-05-27 | 2026-05-26 | 8-K | 0001935979-26-000048 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001274173-26-000140 | View SEC Doc Filr Page |
| 8-K | 2026-05-05 | 2026-05-04 | 8-K | 0001628280-26-030579 | View SEC Doc Filr Page |
| 424B5 | 2026-05-04 | — | 424B5 | 0001628280-26-029924 | View SEC Doc Filr Page |
| S-3ASR | 2026-05-04 | — | S-3ASR | 0001628280-26-029834 | View SEC Doc Filr Page |
| 10-Q | 2026-05-04 | 2026-03-31 | 10-Q | 0001935979-26-000045 | View SEC Doc Filr Page |
| 8-K | 2026-05-04 | 2026-05-04 | 8-K | 0001935979-26-000044 | View SEC Doc Filr Page |
| 8-K | 2026-05-04 | 2026-04-28 | 8-K | 0001935979-26-000042 | View SEC Doc Filr Page |
| 4 | 2026-04-30 | 2026-04-28 | FORM 4 | 0001850520-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-04-30 | 2026-04-28 | FORM 4 | 0001329505-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-04-30 | 2026-04-28 | FORM 4 | 0001448914-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-04-30 | 2026-04-28 | FORM 4 | 0001926476-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-04-30 | 2026-04-28 | FORM 4 | 0001027035-26-000008 | View SEC Doc Filr Page |